ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation.
暂无分享,去创建一个
F. de Marinis | R. Rosell | B. Massuti | A. Giménez-Capitán | N. Karachaliou | A. Vergnenègre | E. Carcereny | T. Morán | A. Drozdowskyj | M. Molina | S. Viteri | C. Teixidó | B. Massutí